"Florida Cancer Specialists provides the most advanced cancer treatment options available, close to home, and personalized for each patient’s unique needs. At our Fort Myers Cancer Center, we provide treatment for all forms of cancers and blood disorders, including laboratory, pharmacy, radiology, nutrition counseling and care management. Clinical trials and Dignicap® available."

During the past decade, Florida Cancer Specialists conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 116 clinical trials were completed, i.e. on average, 113.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 54 clinical trials were completed. i.e. 122.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Specialists" #1 sponsor was "SCRI Development Innovations, LLC" with 69 trials, followed by "Novartis Pharmaceuticals" with 24 trials sponsored, "Eli Lilly and Company" with 18 trials sponsored, "Pfizer" with 14 trials sponsored and "Bristol-Myers Squibb" with 14 trials sponsored. Other sponsors include 116 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists" #1 collaborator was "Genentech, Inc." with 23 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator, "Novartis" with 9 trials as a collaborator, "Bayer" with 8 trials as a collaborator and "Eli Lilly and Company" with 8 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists" are "Breast Cancer" (26 trials), "Metastatic Breast Cancer" (12 trials), "Non-Small Cell Lung Cancer" (10 trials), "Multiple Myeloma" (9 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "Florida Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists" are "Drug" (243 trials), "Biological" (13 trials), "Other" (12 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Bevacizumab" (22 trials), "Carboplatin" (21 trials), "Gemcitabine" (16 trials) and "Paclitaxel" (14 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists" are 206 trials for "All" genders, 34 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists". undefined are not yet recruiting, 25 are recruiting, 32 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 164 completed trials in Florida Cancer Specialists, undefined suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists, 34 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 3 trials that are defined as “Not Applicable".